Additionally, the concentrations of rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA) were increased in 20/22 (90.9%) and 15/22 (68.2%) patients with RA, and some values exceeded the limit of quantification (Table 1). This evidence concerns the gene PRTN3 and rheumatoid arthritis.